No Data
Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement
Wednesday, Takeda Pharmaceutical Co Ltd's (NYSE:TAK) dengue vaccine received World Health Organization's (WHO) prequalification. TAK-003 is the second dengue vaccine to be prequalified by WHO. The pre
When a bloody business meets a “pie falling from the sky”, will Novavax (NVAX.US) be a savior or vase for Sanofi (SNY.US)?
As the impact of the public health incident subsided, global COVID-19 vaccine sales declined sharply, and COVID-19 vaccine dividends also declined sharply. The results of the global vaccine sector in 2023 continued the sharp decline in 2022. The Zhitong Finance App observed that of the 12 listed companies in the A-share vaccine sector, 9 experienced a decline in net profit; while in the US stock market, Moderna (MRNA.US), one of the top three mRNA vaccine giants, fell 64.45% year on year in 2023, and BioNTech (BNTX.US)'s revenue for the same period fell 77.94% year on year. Novav
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading
Telecoms stocks led European equities traded in the US as American depositary receipts slightly higher Tuesday morning, rising 0.15% to 1,420.65 on the S&P Europe Select ADR Index. From continental Eu
Buy Rating Affirmed for Fulcrum Therapeutics: Licensing Deal With Sanofi and Promising Phase 3 Study
Trending Tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax